PALI-2108 for Ulcerative Colitis

PALI-2108 for Ulcerative Colitis
71%60%49%Apr 26Apr 27Apr 28Apr 29Apr 30May 1May 2May 3May 4May 5May 6May 7May 8May 9May 10May 11May 12Apr 26 • YES 66.4%Apr 27 • YES 61.0%Apr 28 • YES 58.8%Apr 29 • YES 56.0%Apr 30 • YES 54.3%May 1 • YES 53.6%May 2 • YES 53.6%May 3 • YES 53.6%May 4 • YES 53.6%May 5 • YES 53.6%May 7 • YES 54.8%May 8 • YES 56.5%May 11 • YES 56.8%May 12 • YES 56.8%
Palisade Bio ($PALI)
No stock closeNo stock close$2.18$1.96$1.75Apr 26Apr 27Apr 28Apr 29Apr 30May 1May 2May 3May 4May 5May 6May 7May 8May 9May 10May 11May 12Apr 27 • PALI $1.96Apr 28 • PALI $1.95Apr 29 • PALI $1.93Apr 30 • PALI $2.00May 1 • PALI $1.99May 4 • PALI $2.13May 5 • PALI $1.97May 6 • PALI $2.00May 7 • PALI $1.99May 8 • PALI $1.80May 11 • PALI $1.94May 12 • PALI $1.92

Will this trial show a positive result on incidence of Treatment-Emergent Adverse Events (TEAE) or abnormal clinical laboratory measure, electrocardiogram (ECG), or vital sign. [ Safety and Tolerability ]?

Paper Trading
Create account to trade
ClinicalTrialModel PositionsModel ReasoningOracle
Scientific editorial illustration for Ulcerative Colitis

Ulcerative Colitis

Ulcerative colitis is a long-term colon disease that causes inflammation, diarrhea, bleeding, and belly pain. This early study tracks side effects and lab changes, which matters because safer medicines can be tested for easing flares.

1North American Prevalence: >400 per 100,0002Outside-Colon Problems: ~27%35-Year Serious Burden: 20% hospitalized; 7% colectomy